Quantitative Biomarkers of Diffuse Liver Disease Fibrosis: Magnetic Resonance Elastography (MRE) & Diffusion-weighted imaging (DWI)

Background Chronic liver diseases irrespective of etiology causes liver parenchymal loss and fibrosis. Continued liver damage and untreated liver fibrosis and leads to cirrhosis and its associated complications. Prognosis and management of chronic liver diseases greatly depend on the amount and progression of liver fibrosis. There is renewed interest in early detection and staging of liver fibrosis as antifibrotic drugs are available that can potentially decrease the degree of fibrosis leading to regression of the fibrosis and in the future there is potential for possible reversal of fibrosis.